Barclays Bank 'Research Arm' Recommends Buying Barclays StockMark Melin
Investec, the stock research arm of Barclays Bank, is making a strong recommendation to buy Barclays PLC (ADR) (NYSE:BCS) (LON:BARC) as it notes “discriminatory regulatory behavior” as a potential risk to the stock price.
Investec notes Barclays underlines performance beat
In a report titled “And now you’re gonna believe us…the tNAV’s going up!” the research arm of the bank noted a 25 percent underlying performance “beat” relative to consensus exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email email@example.com and we will get back to you as quick as humanly possible